PROBIOMED
Proven leadership in every sphere Sandra Sánchez ’ s agenda goes well beyond being the CEO for one of the country ’ s most important pharmaceutical companies . She has held — or currently holds — other positions and memberships in different organizations within the pharmaceutical industry and in other fields :
• President of Asociación Mexicana de Industrias de Investigación Farmacéutica ( AMIIF )
• Consejo para el Fomento de la Ética Médica , Dispensación y uso Racional de Medicamentos ( COFEMEDIR )
• Counsel for the National Chamber of the Pharmaceutical Industry
• Counsel for the American Chamber of Commerce of Mexico ( AMCHAM )
• Board member of Mexican nanotechnology company GRESMEX
• Board member of Farmapiel Laboratories
• Board member of the Vertice excellence program , for Anahuac University
• Mentor for Endeavor Mexico
• Member of the editorial advisory board for Reforma daily newspaper
• Board member for Save The Children – Mexico ( NGO )
Building a legacy Sánchez is the perfect fit to lead PROBIOMED into the challenging times ahead , as she provides affordable biosimilar products to patients worldwide and carrying forth the company ’ s mission .
Her goals for PROBIOMED during 2016 include :
• Compliance with new regulations for biosimilars .
• Expand sales and international presence .
• Continue with biosimilar medical products R & D , focused on chronicdegenerative conditions . These goals provide for an optimistic forecast from Sánchez . “ In the next 10-15 years , Mexico is about to experience its largest demographic window ,” she said . “ We must ensure our population is healthy to guarantee more productivity , a larger economic impact and increasing our competitiveness . Mexico should make the most out of this opportunity if we all commit to this purpose ,” she said .
17